Literature DB >> 23819767

The type 2B p.R1306W natural mutation of von Willebrand factor dramatically enhances the multimer sensitivity to shear stress.

G L Scaglione1, S Lancellotti, M Papi, M De Spirito, A Maiorana, L Baronciani, M T Pagliari, A Arcovito, E Di Stasio, F Peyvandi, R De Cristofaro.   

Abstract

BACKGROUND: Shear stress triggers conformational stretching of von Willebrand factor (VWF), which is responsible for its self-association and binding to the platelet receptor glycoprotein (GP)Ibα. This phenomenon supports primary hemostasis under flow. Type 2B VWF natural mutants are considered to have increased affinity for platelet GPIbα.
OBJECTIVES: To assess the mechanism responsible for the enhanced interaction of the p.R1306W VWF mutant with the platelet receptor.
METHODS: The interaction of GPIbα with wild-type (WT) and p.R1306W VWF multimers and A1-A2-A3 constructs was investigated with surface plasmon resonance spectroscopy. Analysis of the static VWF conformation in solution was performed with dynamic light scattering spectroscopy. The shear stress-induced self-association of VWF multimers was investigated with atomic force microscopy (AFM) over a 0-60 dyn cm(-2) range.
RESULTS: WT VWF did not interact with GPIbα under static conditions, whereas the mutant at ~ 2 μg mL(-1) already bound to the receptor. By contrast, the WT and p.R1306W-A1-A2-A3 constructs showed comparable affinities for GPIbα (Kd  ~ 20 nm). The hydrodynamic diameter of resting R1306W VWF multimers was significantly greater than that of the wild type (210 ± 60 nm vs. 87 ± 22 nm). At shear forces of < 14 dyn cm(-2) , the p.R1306W multimers rapidly changed conformation, entering a regime of self-aggregation, which, in contrast, was induced for WT VWF by shear forces of > 30 dyn cm(-2) . Mechanical stretching AFM experiments showed that p.R1306W multimers needed less energy per length unit (~ 10 pN) to be stretched than the WT protein.
CONCLUSIONS: The increased affinity of p.R1306W VWF for GPIbα arises mostly from higher sensitivity to shear stress, which facilitates exposure of GPIbα binding sites.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  Microscopy, atomic force; platelet adhesiveness; surface plasmon resonance; von Willebrand Factor; von Willebrand disease, Type 2; von Willebrand diseases

Mesh:

Substances:

Year:  2013        PMID: 23819767     DOI: 10.1111/jth.12346

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain.

Authors:  Changjie Zhang; Anju Kelkar; Sriram Neelamegham
Journal:  Blood Adv       Date:  2019-04-09

2.  Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains.

Authors:  Monica Sacco; Stefano Lancellotti; Mattia Ferrarese; Francesco Bernardi; Mirko Pinotti; Maira Tardugno; Erica De Candia; Leonardo Di Gennaro; Maria Basso; Betti Giusti; Massimiliano Papi; Giordano Perini; Giancarlo Castaman; Raimondo De Cristofaro
Journal:  Blood Adv       Date:  2020-07-28

3.  The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding.

Authors:  D'Andra N Parker; Subia Tasneem; Richard W Farndale; Dominique Bihan; J Evan Sadler; Silvie Sebastian; Philip G de Groot; Catherine P M Hayward
Journal:  Thromb Haemost       Date:  2016-04-07       Impact factor: 5.249

Review 4.  Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases.

Authors:  Stefano Lancellotti; Maria Basso; Raimondo De Cristofaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

5.  A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation.

Authors:  Frédéric Adam; Caterina Casari; Nicolas Prévost; Alexandre Kauskot; Cécile Loubière; Paulette Legendre; Christelle Repérant; Dominique Baruch; Jean-Philippe Rosa; Marijke Bryckaert; Philip G de Groot; Olivier D Christophe; Peter J Lenting; Cécile V Denis
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.